Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in
the world. Given that the burden of chronic liver disease is expected to rise owing to …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is
estimated to cause approximately half a million deaths annually. Because of its high fatality …

Since the 1970s, the epidemic of hepatocellular carcinoma (HCC) has spread beyond the
Eastern Asian predominance and has been increasing in Northern hemisphere, especially …

Liver cancer is one of the leading causes of cancer-related mortality around the world.
Hepatocellular carcinoma (HCC) is the primary cancer of the liver, accounting for the …

Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …

Primary liver cancer (namely hepatocellular carcinoma, HCC) is worldwide the fifth most
common cancer in men and the seventh one in women, and it represents the third most …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with about 600,000 patients dying from the disease annually. In 70–90%, HCC …

Hepatocellular carcinoma (HCC) is increasing in incidence and has a very high fatality rate.
Cirrhosis due to chronic hepatitis B or hepatitis C is the leading risk factor for HCC. Global …

Hepatocellular Carcinoma (HCC) is a highly aggressive cancer with mortality running
parallel to its incidence and has limited therapeutic options. Chronic liver inflammation and …

Hepatocellular carcinoma (HCC) is a major worldwide public health concern. Despite recent
advances, there has been little success in improving the survival of HCC patients. Due to …